Cinnarizine-induced parkinsonism in primates

Clin Neuropharmacol. 1992 Apr;15(2):152-4. doi: 10.1097/00002826-199204000-00010.

Abstract

We describe the production of an experimental model of parkinsonism induced by cinnarizine (CNZ) in three healthy sylvanna monkeys. The drug produced a severe but reversible parkinsonism in all animals. After discontinuation of CNZ, all animals recovered but the oldest one was akinetic for 6 weeks. CNZ produced a persistent reduction in HVA and 5-HIAA levels in the CSF. Our data suggest a predominant presynaptic effect on DA and 5-HT neurons; and could account for the longstanding parkinsonism induced by calcium antagonist in some patients as well as the depression observed in these subjects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biogenic Monoamines / cerebrospinal fluid
  • Cinnarizine*
  • Disease Models, Animal
  • Dopamine / physiology
  • Haplorhini
  • Homovanillic Acid / cerebrospinal fluid
  • Hydroxyindoleacetic Acid / cerebrospinal fluid
  • Male
  • Movement Disorders / etiology
  • Parkinson Disease, Secondary / cerebrospinal fluid
  • Parkinson Disease, Secondary / chemically induced*
  • Tremor / chemically induced

Substances

  • Biogenic Monoamines
  • Cinnarizine
  • Hydroxyindoleacetic Acid
  • Dopamine
  • Homovanillic Acid